Home |
| Apply
Now | Editor FAQ | About | Nyaya
Health | ProEdit
Japan
About EquityEdit: Management
Board of Directors
Brian Taylor Slingsby,
Duncan
Smith-Rohrberg Maru, MPhil. Founding Board Member.
Mr.
Maru is an MD/PhD candidate at
Christopher Belknap. Board Member.
Mr. Belknap is a 4th year undergraduate at
Sanjay
Basu, MSc. Board Member. Mr. Basu is an
MD/PhD candidate at
Ellen
Tarr, PhD. Board
Member. Dr. Tarr is a postdoctoral researcher at
the University of
Kansas and a senior editor for EquityEdit. As part of the IRACDA
post-doctoral program at KU, she taught for three years at Haskell
Indian Nations University, a minority-serving institution with an
exclusively Native American enrollment. Her current research
interests are comparative immunology and host-pathogen interactions,
specifically immune defense mechanisms in nematodes and parasitic
nematode infections. Her previous work has been published in
Molecular and Biochemical Parasitology, Trends
in
Parasitology, and Gene. Pubmed
references.
Management Structure
To maximize revenue to participating non-profit beneficiaries, the
management team of EquityEdit remains all-volunteer. Since these
volunteers are unpaid, other incentives exist to create a sustainable
management structure. The primary incentive is their desire to
fundraise for the nonprofit beneficiary. To facilitate this, a major
criteria for an EquityEdit beneficiary (in addition to being small,
innovative, pro-poor) is that they have at least one executive or board
member who is qualified and interested in improving EquityEdit. This is
a key aspect of developing a sustainable model that doesn't require a
paid executive director, since the beneficiary executive would be
significantly invested in the financial success of EquityEdit. Once a
non-profit joins, the goal would be to quickly expand to and sustain
annual revenue streams for the non-profit. This revenue
would continue for at least five years, during which time the
point-person at the non-profit would be expected to engage in improving
EquityEdit.
Board of Directors
Board of Advisors
David Berg, Ph.D., Psychologist, Yale University
School of Medicine
Matt Cockerill, Ph.D., Publisher, Biomed Central
Emma Hitt,
Ph.D., Biomedical Editor, Hitt Medical Writing
John
McConnell, Editor, Lancet Infectious Diseases
George
Stefano, Ph.D., Editor-in-Chief, Medical Science Monitor
Gavin
Yamey, Senior Editor, PLoS Medicine